Balyasny Asset Management LLC Durect Corp Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.64 $22,022 - $37,091	57,955 New	57,955 $28,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $64,600 - $102,995	-60,944 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $48,793 - $78,507	31,278 Added 105.43%	60,944 $95,000
Q1 2018 May 15, 2018	BUY	$0.91 - $2.24 $26,996 - $66,451	29,666 New	29,666 $63,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.